Product Information
DEXMETHYLPHENIDATE ER 30 MG CP is a generic product labeled by Granules Pharmaceuticals Inc., priced at $1.7969 per EA under NDC 70010000901. Its NADAC has been published 281 times since Feb 10, 2021.
Strength
30 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010000901
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213813On Market Since
12/1/2020
Pharmacological Classes
Price Statistics
The NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has been published 281 times since Feb 10, 2021, and over the history we have for it it has declined 62.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7969 per EA |
|---|---|
| All-time high | $4.7909 (Feb 10, 2021) |
| All-time low | $0.7499 (May 22, 2024) |
| 52-week high | $2.1565 |
| 52-week low | $1.4839 |
| Median price | $1.7255 |
| Average price | $1.7578 |
| Largest weekly change | +83.4% (Aug 18, 2021) |
| Weeks tracked | 281 |
| Tracking since | Feb 10, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the DEXMETHYLPHENIDATE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DEXMETHYLPHENIDATE ER 30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE ER 30 MG CP, manufactured by Granules Pharmaceuticals Inc., is $1.7969 per EA (NDC 70010000901), effective Jun 24, 2026.
How has the price of DEXMETHYLPHENIDATE ER 30 MG CP changed over time?
Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has declined 62.5%. It has been tracked across 281 weekly CMS publications since Feb 10, 2021.
What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE ER 30 MG CP?
Since Feb 10, 2021, the NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has ranged from a low of $0.7499 (May 22, 2024) to a high of $4.7909 (Feb 10, 2021), with a median of $1.7255 per EA.
Are there cheaper alternatives to DEXMETHYLPHENIDATE ER 30 MG CP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DEXMETHYLPHENIDATE ER 30 MG CP, so no direct lower-cost alternative is listed.
Who manufactures DEXMETHYLPHENIDATE ER 30 MG CP?
DEXMETHYLPHENIDATE ER 30 MG CP (NDC 70010000901) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification